Dermatitis, Seborrheic

Dermatology
4
Pipeline Programs
2
Companies
2
Clinical Trials
3
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
4
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 1 programs with unclassified modality

On Market (3)

Approved therapies currently available

U
EXTINAApproved
ketoconazole
Unknown Company
topical2007
U
KETOCONAZOLEApproved
ketoconazole
Unknown Company
oral1999
U
XOLEGELApproved
ketoconazole
Unknown Company
topical2006

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GSK
GSKLONDON, United Kingdom
1 program
1
KetoconazolePhase 4Small Molecule1 trial
Active Trials
NCT00703846Completed498Est. Apr 2010
Pierre Fabre
Pierre FabreFrance - Aignan
1 program
Phase 1: short intensive treatment phaseN/A1 trial
Active Trials
NCT06578962Completed63Est. May 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GSKKetoconazole
Pierre FabrePhase 1: short intensive treatment phase

Clinical Trials (2)

Total enrollment: 561 patients across 2 trials

NCT00703846GSKKetoconazole

STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%

Start: Jun 2008Est. completion: Apr 2010498 patients
Phase 4Completed
NCT06578962Pierre FabrePhase 1: short intensive treatment phase

Efficacy of a Cosmetic Shampoo RV3438G in Reccurent Squamous States

Start: Nov 2020Est. completion: May 202163 patients
N/ACompleted

Related Jobs in Dermatology

MSL/Senior MSL, Dermatology - Tampa, Florida

AbbVie
Remote
11h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
11h ago

Regional Sales Trainer - Dermatology (Central / West Regions)

AbbVie
Remote
12h ago

Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)

AbbVie
Remote
12h ago

Delegado Especialista Ventas Dermatología (Inmunología)

AbbVie
Remote
17h ago

Senior Manager, HTA, Value and Evidence (HV&E), Medical Dermatology

Pfizer
United States - New York - New York City
Yesterday
$139K - $232K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Dermatitis, Atopic(42)Hidradenitis Suppurativa(30)Chronic Spontaneous Urticaria(21)Alopecia Areata(17)Hidradenitis Suppurativa (HS)(10)Vitiligo(9)Rosacea(6)Chronic Urticaria(5)Pruritus(5)Androgenetic Alopecia(5)